Eos Advisory
Eos invests in & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
We are a trusted link between non-specialist investors & highly specialist investments, through relationships that are systematic, far-sighted & bold. Founded in 2014 initially as an angel investment syndicate, building sector focus, a Scottish network and an early-stage portfolio, we scaled in 2021, with the launch of an annual Innovation Fund (EIS) and later-stage Venture Partner investors, working alongside the syndicate, as well as building our executive team and international networks.
With deep roots in Scotland and a global mindset, Eos is a leading investor within four impact areas:
- Disease, diagnosis, prevention and treatment.
- Food and water security.
- Energy security, climate change & pollution.
- Improvement and sustainability of industrial processes.
Eos invests across the UK, but only in companies whose addressable market is global. The focus on Scotland is because of:
- a global reputation for innovation & university research, built over centuries,
- our strongest network & first access to relevant deal flow,
- our hands on approach to supporting portfolio companies.
All portfolio companies are focussed on either improving quality of life or environmental sustainability. Historically, first round investments have been in the £500k to £3M range, with growth rounds up to £10M and we actively work with a global network of co-investors who can also add value to portfolio companies.